News
Updated efficacy results of olverembatinib (HQP1351) in patients with tyrosine kinase inhibitor (TKI)-resistant succinate dehydrogenase (SDH)-deficient gastrointestinal stromal tumors (GIST) and ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback